Skip to Content

Join the 'Onychomycosis' group to help and get support from people like you.

Onychomycosis News

Related terms: Fungal Infection, Nails, Infection, Fungal, Nails, Nails, Fungal Infection, Tinea Unguium

Health Tip: Recognizing Toenail Fungus

Posted 10 Jun 2016 by Drugs.com

-- Tiny fungi can creep under your toenails and cause an infection, leading to a number of unpleasant symptoms. The American Podiatric Medical Association says signs of toenail fungus include nails that: Are darker white or more yellow than usual. Have a strong odor. Accumulate debris below the surface, such as white flecks. Become thick and may be difficult to cut. Are infected and transmit that infection to neighboring nails. Are painful, making it more difficult to walk. Read more

Related support groups: Onychomycosis - Toenail, Onychomycosis, Foot Care

Health Tip: Protect Your Hands While Gardening

Posted 26 May 2016 by Drugs.com

-- Digging and weeding can pose dangers for your hands, so use caution while working in your garden. The American Society for Surgery of the Hand suggests these precautions: Wear a pair of leather gloves to protect hands from bites, scratches, blisters, poison ivy, chemicals, fertilizers, bacteria and sunburn. Perform a different task every 15 minutes to avoid repetitive use of the same muscles. Such tasks include: raking, digging, planting, trimming or pruning. Use a small hand shovel to dig, to avoid cuts from buried debris. Make sure any sharp tool has a safety lock. Only use such as tool as intended. Practice proper body posture. And make sure your wrists are relaxed and straight (not bent) for maximum strength. Avoid tools with grooves on the handles that are meant to improve grip. If such tools don't fit your hand, they can lead to soreness and calluses. Read more

Related support groups: Onychomycosis - Toenail, Onychomycosis - Fingernail, Onychomycosis, Scrapes, Minor Cuts, Minor Skin Conditions, Minor Skin Irritation

FDA Medwatch Alert: Nizoral (ketoconazole) Oral Tablets: Drug Safety Communication - Prescribing for Unapproved Uses including Skin and Nail Infections Continues; Linked to Patient Death

Posted 23 May 2016 by Drugs.com

ISSUE: FDA is warning health care professionals to avoid prescribing the antifungal medicine ketoconazole oral tablets to treat skin and nail fungal infections. Use of this medication carries the risk of serious liver damage, adrenal gland problems, and harmful interactions with other medicines that outweigh its benefit in treating these conditions, which are not approved uses of the drug. FDA approved label changes for oral ketoconazole tablets in 2013 to reflect these serious risks and to remove the indications for treatment of skin and nail fungal infections. However, an FDA safety review found that oral ketoconazole continues to be prescribed for these types of conditions. Since the 2013 labeling change, one patient death has been reported to the FDA due to liver failure associated with oral ketoconazole prescribed to treat a fungal infection of the nails.  See the full Drug Safety ... Read more

Related support groups: Tinea Corporis, Ketoconazole, Onychomycosis - Toenail, Tinea Cruris, Diaper Rash, Nizoral, Cutaneous Candidiasis, Tinea Barbae, Tinea Versicolor, Onychomycosis - Fingernail, Tinea Pedis, Tinea Capitis, Onychomycosis, Chronic Mucocutaneous Candidiasis, Dermatophytosis, See also Cutaneous Fungal Infections, Cutaneous Sporotrichosis, Chromomycosis, Eumycetoma, Cutaneous Fungal Infection

Health Tip: Recognizing Signs of Nail Fungus

Posted 18 Sep 2015 by Drugs.com

-- If you frequent public showers or pools and don't always don your shoes, you may be more prone to nail fungus, a condition medically known as onychomycosis. The Mayo Clinic says common symptoms include nails that are: Unusually thick. Crumbly and brittle. Ragged. Dull with no shine. Abnormally shaped. Unusually dark. Read more

Related support groups: Fluconazole, Diflucan, Clotrimazole, Ketoconazole, Miconazole, Onychomycosis - Toenail, Nizoral, Itraconazole, Onychomycosis - Fingernail, Onychomycosis, Sporanox, Voriconazole, Mycelex Troche, Cresemba, Vfend, Oravig, Noxafil, Clotrimazole Troche, Paronychia, Posaconazole

FDA Approves Kerydin (tavaborole) Topical Solution for Onychomycosis of the Toenails

Posted 8 Jul 2014 by Drugs.com

PALO ALTO, Calif. July 8, 2014--(BUSINESS WIRE)-- Anacor Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application for Kerydin (tavaborole) topical solution, 5%, the first oxaborole antifungal approved for the topical treatment of onychomycosis of the toenails. Onychomycosis is a fungal infection of the nail and nail bed that affects approximately 35 million people in the United States, according to Podiatry Today. "We are pleased to announce the FDA approval of Kerydin, which provides an important new topical treatment option for the millions of people in the United States who are infected with onychomycosis of the toenails," said Paul Berns, Chief Executive Officer of Anacor Pharmaceuticals. "We expect to launch Kerydin in the U.S., either alone or with a partner, as early as the end of this quarter." "Onychomycosis ... Read more

Related support groups: Onychomycosis - Toenail, Onychomycosis

Valeant Pharmaceuticals Announces FDA Approval Of Jublia for the Treatment of Onychomycosis

Posted 11 Jun 2014 by Drugs.com

LAVAL, Quebec, June 9, 2014 /PRNewswire/ – Valeant Pharmaceuticals International, Inc. today announced that that its wholly owned subsidiary, Valeant Pharmaceuticals North America LLC, received notice that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Jublia (efinaconazole 10% topical solution), the first topical triazole approved for the treatment of onychomycosis of the toenails. "We acquired Jublia through our purchase of Dow Pharmaceutical Sciences in 2008 and advanced Jublia from pre-IND stage through Clinical Phases 1, 2 and 3," said J. Michael Pearson, chairman and chief executive officer. "We are working quickly to get this important product launched in the U.S. and Canada in the third quarter of 2014. We anticipate favorable managed care coverage in the U.S., similar to other branded antifungal agents, with peak sales of $300-$800 ... Read more

Related support groups: Onychomycosis - Toenail, Onychomycosis

Ask a Question

Further Information

Related Condition Support Groups

Onychomycosis - Toenail, Onychomycosis - Fingernail, Cutaneous Fungal Infection

Related Drug Support Groups

hydroxypropyl chitosan / terbinafine, undecylenic acid, Desenex, Fungi-Nail, Blis-To-Sol Powder, Fungisil, Cruex, Trifungol, Protectol, Undelenic